BioMarck Pharmaceuticals biomarck.com


Public lists: Pharma Startups (4732)

BioMarck Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of drugs for the treatment of pulmonary diseases and disorders associated with the over-secretion of mucus and pulmonary inflammation. In developing its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma, and cystic fibrosis are later disease targets. BIO-1...Show all

BioMarck Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of drugs for the treatment of pulmonary diseases and disorders associated with the over-secretion of mucus and pulmonary inflammation. In developing it...Show all

Company (Alive / Active)

Phone: 844-424-6627

Fax:

2530 Meridian Parkway
Suite 300
Durham, 27713
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
BioMarck Pharmaceuticals $21.5M Feb 8, 2017
See all 57 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related BioMarck Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 57 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods for attenuating release of inflammatory mediators and peptides useful therein Mar 04, 2015 Nov 28, 2017 Patent
Mucin hypersecretion inhibitors and methods of use Nov 10, 2014 Mar 21, 2017 Patent
Inhibitors of metastasis Apr 07, 2014 Aug 09, 2016 Patent
Methods for attenuating release of inflammatory mediators and peptides useful therein Jan 26, 2009 Apr 07, 2015 Patent
Mucin hypersecretion inhibitors and methods of use Jun 28, 2013 Dec 09, 2014 Patent
See all 13 patents